Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Class A Common Shares
-
Shares outstanding
-
117,125,812
-
Total 13F shares
-
7,719,601
-
Share change
-
+226,300
-
Total reported value
-
$7,435,013
-
Put/Call ratio
-
6.6%
-
Price per share
-
$0.97
-
Number of holders
-
38
-
Value change
-
+$182,305
-
Number of buys
-
18
-
Number of sells
-
18
Institutional Holders of Cardiol Therapeutics Inc. - Class A Common Shares (CRDL) as of Q1 2025
As of 31 Mar 2025,
Cardiol Therapeutics Inc. - Class A Common Shares (CRDL) was held by
38 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,719,601 shares.
The largest 10 holders included
Tejara Capital Ltd, AdvisorShares Investments LLC, MMCAP International Inc. SPC, UBS Group AG, PVG ASSET MANAGEMENT CORP, Lion Street Advisors, LLC, ENVESTNET ASSET MANAGEMENT INC, Cambridge Investment Research Advisors, Inc., Atria Investments, Inc, and Knoll Capital Management, LLC.
This page lists
38
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.